期刊文献+

肺炎链球菌表面黏附素A的原核表达和抗原性分析 被引量:3

Study on prokaryotic expression and antigenicity of pneumococcal surface adhesin A
下载PDF
导出
摘要 目的应用基因工程技术制备肺炎链球菌表面黏附素A(pneumococcal surface adhesin A,PsaA),并分析其抗原性。方法根据基因库中报道的psaA基因序列,从肺炎链球菌基因组中扩增出psaA基因,连接到原核表达载体pET28a中,构建出重组质粒pET28a-psaA,转化大肠杆菌BL21(DE3),采用镍柱亲和层析法纯化PsaA蛋白,Western-blot分析其抗原性。结果克隆出的psaA基因同基因库中报道的psaA基因序列一致。成功构建出重组质粒pET28a-psaA,基因测序证实重组质粒构建正确。成功表达和纯化出PsaA蛋白,十二烷基硫酸钠-聚丙烯酰胺凝胶电泳显示蛋白分子量为37-kDa,最终得到纯度较高的蛋白,主要以可溶性形式存在,Western-blot分析显示在37-kDa处见到目的蛋白条带。结论利用基因工程技术可以克隆出psaA基因,并成功表达和纯化出PsaA蛋白,其抗原性良好。 Objective To prepare the pneumococcal surface adhesin A(PsaA) with genetic engineering technology and to analyze its antigenicity. Methods Bank on the sequence ofpsaA gene in the Genebank,a pair of primers were designed and psaA gene was amplified from the genomes of Streptococcus pneumoniae. By gene recombination technology in vitro, sequence psaA was cloned into prokaryotic expression vector pET28a to construct pET28a- psaA recombinant plasmid. After being confirmed by DNA sequencing, expressed antigen protein was purified by affinity chromatography and the antigenicity of the expressed protein was confirmed by Western blotting assay. Results The cloned psaA gene was consistent with Genbank data by gone sequencing. A recombinant expression plasmid pET28a-psaA was constructed successfully and could stablely express about a 37-kD protein in E. coli BI21 (DE3) ,mainly exsited in the form of solution. The PsaA matigenicity was proved by Western blotting assay. Conclusions The psaA gene was successfully cloned, and the recombinant PsaA protein was expressed and purified, so that it can provide an experimental basis for the further research of the protein vaccine of otitis media.
出处 《中国眼耳鼻喉科杂志》 2009年第1期20-22,I0003,共4页 Chinese Journal of Ophthalmology and Otorhinolaryngology
基金 上海市科学技术委员会科研计划项目资助(06JC14014)
关键词 中耳炎 链球菌 肺炎 疫苗 肺炎球菌菌苗 Otitis media Streptococcus pneumoniae Vaccines Pneumococcal vaccines
  • 相关文献

参考文献8

  • 1ESKOLA J, KILPI T, PALMU A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media [J]. N Engl J Med, 2001,344(6) :403-.409.
  • 2PARK I H,PRITCHARD D G,CARTEE R,et al. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae [J]. J Clin Microbiol, 2007,45 (4) : 1225-1233.
  • 3BRILES D E, HOLLINGSHEAD S K, NABORS G S,et al. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae[ J ]. Vaccine ,2001,19 ( 15 ) :87-95.
  • 4KARMA P. Vaccination and otitis media [ J ]. ORL, 2002,64 (2) : 80-85.
  • 5SIPIL M, PUKANDER J, KARMA P. Occurrence and recurrence of acuteotitis media among children [ J ]. Acta Otolaryngol, 1987,104 (1- 2) :138-145.
  • 6HANAGE W P, AURANEN K, SYRJANEN R, et al. Ability of pneumococcal serotypes and clones to cause acute otitis media: Implications for the prevention of otitis media by conjugate vaccines[ J]. Infect Immun, 2004,72( 1 ) :76-81.
  • 7RUSSELL H,THARPE J A, WELLS D E,et al. Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae [J]. J Clin Microbiol, 1990, 28(9) : 2191-2195.
  • 8BRILES D E,ADES E,PATON J C,et al. lntranasal immunization of mice with a mixture of the pneumococcal proteins psaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae [ J ]. Infect Immun, 2000,68 (2) :796-800.

同被引文献27

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部